{{Drugbox
| Verifiedfields = changed
| verifiedrevid = 461116090
| IUPAC_name =  
| image = Gadoversetamide.png
| width = 250
| image2 = Gadoversetamide3D.png
<!--Clinical data-->
| tradename =  
| Drugs.com = {{drugs.com|CONS|gadoversetamide}}
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = C
| pregnancy_category =  
| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 -->
| legal_CA = <!--             / Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK = <!-- GSL         / P       / POM / CD / Class A, B, C -->
| legal_US = <!-- OTC                   / Rx-only  / Schedule I, II, III, IV, V -->
| legal_status =  
| routes_of_administration = [[Intravenous therapy|Intravenous]]
<!--Pharmacokinetic data-->
| bioavailability =  
| protein_bound = Nil
| metabolism = Nil
| elimination_half-life = 80 to 120 minutes
| excretion = [[Kidney|Renal]]
<!--Identifiers-->
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 131069-91-5
| ATC_prefix = V08
| ATC_suffix = CA06
| PubChem = 6435809
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank = DB00538
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 392041
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = RLM74T3Z9D
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D01646
| ChEMBL_Ref = {{ebicite|changed|EBI}}
| ChEMBL = 1200457
<!--Chemical data-->
| C=20 | H=34 | Gd=1 | N=5 | O=10
| molecular_weight = 661.77 g/mol
| smiles = [Gd+3].O=C(NCCOC)CN(CC([O-])=O)CCN(CC([O-])=O)CCN(CC(=O)NCCOC)CC([O-])=O
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C20H37N5O10.Gd/c1-34-9-3-21-16(26)11-24(14-19(30)31)7-5-23(13-18(28)29)6-8-25(15-20(32)33)12-17(27)22-4-10-35-2;/h3-15H2,1-2H3,(H,21,26)(H,22,27)(H,28,29)(H,30,31)(H,32,33);/q;+3/p-3
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = HBEAOBRDTOXWRZ-UHFFFAOYSA-K
}}
'''Gadoversetamide''' is a [[gadolinium-based MRI contrast agent]], particularly for imaging of the [[brain]], [[Vertebral column|spine]] and [[liver]].<ref>{{cite web|url=http://www.drugs.com/MMX/Gadoversetamide.html |title=Gadoversetamide Drug Information |date=2000-03-20 |accessdate=2007-03-23 |publisher=Drugs.com |deadurl=yes |archiveurl=https://web.archive.org/web/20071010060901/http://www.drugs.com/MMX/Gadoversetamide.html |archivedate=2007-10-10 |df= }}</ref> It is marketed under the trade name '''OptiMARK'''.

==Notes==
{{Reflist}}

[[Category:Gadolinium compounds]]
[[Category:MRI contrast agents]]

{{pharma-stub}}
{{Contrast media}}